L020.F BRITANNIA LIFE SCIENCES
- Market cap
- EUR 4.86M
- P/E
- 0.4x
- P/B
- 0.35x
- ROE
- 21.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is L020.F undervalued?
Graham numberThe Graham number of BRITANNIA LIFE SCIENCES cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BRITANNIA LIFE SCIENCES fundamental analysis
No fundamental analysis for BRITANNIA LIFE SCIENCES yet.
BRITANNIA LIFE SCIENCES stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BRITANNIA LIFE SCIENCES
Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. The company serves cosmetics, consumer packaged and household goods, and nutraceutical industries. Britannia Life Sciences Inc. is headquartered in Toronto, Canada.
Full company profileBRITANNIA LIFE SCIENCES financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
BRITANNIA LIFE SCIENCES annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 7.30M | 6.40M | 517K | 369K | 475K | 405K |
| Gross Profit | 5.26M | 4.64M | 138K | 27.3K | 102K | 77.7K |
| Operating Income | -8.36M | 994K | -6.82M | -2.02M | -1.46M | -1.43M |
| EBITDA | - | 6.94M | -5.96M | -4.39M | 13.7M | 4.87M |
| Net Income | -15.5M | 5.08M | -4.77M | 7.39M | 14.7M | 4.79M |
| EPS | -0.10 | 0.03 | -0.03 | 0.05 | 0.09 | 0.03 |
| Balance Sheet | ||||||
| Total Assets | 21.1M | 23.5M | 22.3M | 11.6M | 23.9M | 24.8M |
| Total Liabilities | 15.6M | 12.5M | 15.6M | 5.31M | 3.12M | 2.79M |
| Shareholders' Equity | 1.35M | 7.02M | 2.44M | 6.30M | 20.7M | 22.1M |
| Cash & Short-term Investments | 1.63M | 2.60M | 1.32M | 7.85M | 1.33M | 11.8M |
| Cash Flow | ||||||
| Operating Cash Flow | 2.80M | 2.01M | 2.09M | -2.62M | -1.16M | -2.64M |
| Capital Expenditure | 87.1K | 342K | 337K | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | 2.71M | 1.67M | 2.09M | -2.62M | -1.16M | -2.64M |
| Ratios | ||||||
| ROE | -1,143.0% | 72.4% | -195.6% | 117.3% | 70.6% | 21.7% |
| ROA | -73.3% | 21.6% | -21.4% | 63.7% | 61.4% | 19.3% |
| Net Profit Margin | -211.8% | 79.4% | -922.5% | 2,002.0% | 3,085.5% | 1,182.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
BRITANNIA LIFE SCIENCES dividends
BRITANNIA LIFE SCIENCES has not paid dividends in the last 5 fiscal years.
Who owns BRITANNIA LIFE SCIENCES
- Insiders 34.45%
- Institutions 0.72%
- Public & others 64.84%
- Shares outstanding 165M
- Free float 101M
BRITANNIA LIFE SCIENCES company profile
- Company name
- BRITANNIA LIFE SCIENCES
- Ticker
- L020.F
- ISIN
- CA11042D1087
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- March
- Address
- 120 Adelaide Street West, Toronto, ON, Canada, M5H 1T1
- Phone
- 416 433 9259
- Website
- britannia.life
About BRITANNIA LIFE SCIENCES
Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. The company serves cosmetics, consumer packaged and household goods, and nutraceutical industries. Britannia Life Sciences Inc. is headquartered in Toronto, Canada.
BRITANNIA LIFE SCIENCES management
4- Mr. Peter James Shippen C.A.I.A., C.P.A., CFACEO & Director · born 1981
- Ms. Sarah Zilik C.A., CPASecretary & CFO · born 1980
- Mr. Boris NovanskyPresident
- Micah SimmonsVice President of Corporate Development